Dechert LLP has a fine record in cross-border debt and equity offerings, along with international de-SPAC transactions. It is noted for deals involving permanent capital vehicles (including business development companies) and life sciences companies. Boston's Thomas Friedmann co-heads the capital markets group alongside life sciences specialist David Rosenthal in New York. Stephen Leitzell is another key figure in Philadelphia with particular experience in healthcare and technology.
Legal 500 Editorial commentary
Practice head
The lawyer(s) leading their teams.
Thomas Friedmann, David Rosenthal